Daiwa Securities Group’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-15
Closed 1344
2023
Q3
$0 Hold
15
﹤0.01% 1304
2023
Q2
$1K Hold
15
﹤0.01% 1272
2023
Q1
$7K Hold
15
﹤0.01% 1132
2022
Q4
$6K Buy
15
+2
+15% +$766 ﹤0.01% 1140
2022
Q3
$4K Hold
13
﹤0.01% 1175
2022
Q2
$3K Hold
13
﹤0.01% 1200
2022
Q1
$4K Hold
13
﹤0.01% 1191
2021
Q4
$4K Hold
13
﹤0.01% 1219
2021
Q3
$3K Buy
13
+6
+86% +$2.13K ﹤0.01% 1210
2021
Q2
$5K Hold
7
﹤0.01% 1071
2021
Q1
$6K Hold
7
﹤0.01% 1069
2020
Q4
$6K Sell
7
-13
-65% -$13.7K ﹤0.01% 1046
2020
Q3
$21K Hold
20
﹤0.01% 984
2020
Q2
$17K Hold
20
﹤0.01% 1033
2020
Q1
$17K Hold
20
﹤0.01% 1018
2019
Q4
$21K Sell
20
-2
-9% -$2.04K ﹤0.01% 1010
2019
Q3
$20K Hold
22
﹤0.01% 995
2019
Q2
$25K Hold
22
﹤0.01% 995
2019
Q1
$30K Sell
22
-2
-8% -$2.71K ﹤0.01% 975
2018
Q4
$28K Buy
24
+6
+33% +$6.74K ﹤0.01% 954
2018
Q3
$28K Hold
18
﹤0.01% 986
2018
Q2
$28K Hold
18
﹤0.01% 999
2018
Q1
$21K Buy
+18
New +$23.7K ﹤0.01% 990

Other funds holding KYNB

Daiwa Securities Group's KYNB Position: Q4 2023 in Review

Daiwa Securities Group sold out of Kyntra Bio (KYNB) in Q4 2023, closing a stake of 15 shares.

Daiwa Securities Group first reported a position in KYNB in Q1 2018 and held it in 23 quarters. The position peaked at $30K in Q1 2019. 100 funds tracked by Wall St. Rank hold KYNB as of Q4 2023.

  • Daiwa Securities Group reported no remaining Kyntra Bio position as of Q4 2023 after selling out during the quarter.
  • Daiwa Securities Group sold 15 Kyntra Bio shares in Q4 2023.
  • Daiwa Securities Group first reported a position in Kyntra Bio in Q1 2018 and held it in 23 quarters.
  • Daiwa Securities Group's Kyntra Bio position peaked at $30K in Q1 2019.
  • 100 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2023.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.